Acro Biomedical (ACBM) Cash & Equivalents Growth (3y) (2018 - 2026)
Powered by 
Analysis
Acro Biomedical (ACBM) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 18.71% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | -3.39% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 18.13% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 0.17% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 2.98% |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | -10.38% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -12.19% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 24.17% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | -21.56% |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 10.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.83% |
| Dec 31, 2025 | -11.20% |
| Sep 30, 2025 | -35.60% |
| Jun 30, 2025 | -87.10% |
| Mar 31, 2025 | -91.11% |
| Dec 31, 2024 | -82.90% |
| Sep 30, 2024 | -83.45% |
| Jun 30, 2024 | -83.74% |
| Mar 31, 2024 | -81.63% |
| Dec 31, 2023 | -72.52% |
| Sep 30, 2023 | 175.75% |
| Jun 30, 2023 | 91.60% |
| Mar 31, 2023 | -68.83% |
| Dec 31, 2022 | 85.89% |
| Sep 30, 2022 | 122.38% |
| Jun 30, 2022 | 274.23% |
| Mar 31, 2022 | 853.95% |
| Dec 31, 2021 | 36.31% |
| Sep 30, 2021 | 412.64% |
| Jun 30, 2021 | 260.10% |